Loading viewer...
investor_presentation
Format: PDF investor_presentation
Seres Therapeutics presents its microbiome therapeutics strategy, featuring VOWST, the first FDA-approved orally administered microbiome therapeutic. The deck covers the company's clinical pipeline including the SER-155 Phase 1b study and outlines strategic priorities with financial discipline.
Seres Therapeutics 2017 Cowen Health Care Conference Presentation
conferenceconference
29 Pages
investor_presentation
23 Pages
Perseus Mining
Associate Global Partners APL Investor Presentation August 2024
investor_presentationinvestor_presentation
26 Pages
Associate Global Partners Limited